CD276 and breast cancer: B7H3 exhibits low expression in most normal tissues but is overexpressed in a variety of solid tumors, including melanoma, glioma, lung cancer, pancreatic cancer, ovarian cancer, breast cancer, gastric cancer, and again particularly in breast cancer [4].